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ABSTRACT We have constructed a model of the upper part of the glycolysis in the pancreatic b-cell. The model comprises
the enzymatic reactions from glucokinase to glyceraldehyde-3-phosphate dehydrogenase (GAPD). Our results show, for
a substantial part of the parameter space, an oscillatory behavior of the glycolysis for a large range of glucose concentrations.
We show how the occurrence of oscillations depends on glucokinase, aldolase and/or GAPD activities, and how the oscillation
period depends on the phosphofructokinase activity. We propose that the ratio of glucokinase and aldolase and/or GAPD
activities are adequate as characteristics of the glucose responsiveness, rather than only the glucokinase activity. We also
propose that the rapid equilibrium between different oligomeric forms of phosphofructokinase may reduce the oscillation period
sensitivity to phosphofructokinase activity. Methodologically, we show that a satisfying description of phosphofructokinase
kinetics can be achieved using the irreversible Hill equation with allosteric modiﬁers. We emphasize the use of parameter
ranges rather than ﬁxed values, and the use of operationally well-deﬁned parameters in order for this methodology to be
feasible. The theoretical results presented in this study apply to the study of insulin secretion mechanisms, since glycolytic
oscillations have been proposed as a cause of oscillations in the ATP/ADP ratio which is linked to insulin secretion.
INTRODUCTION
The study of stimulus-secretion coupling in the pancreatic
b-cell is of greatest importance for the understanding of
glucose homeostasis and diabetes. The prevailing main hy-
pothesis of the glucose-mediated stimulus-secretion path-
way is that glucose enters the b-cell via a membrane-bound
glucose transporter and is metabolized in the glycolysis,
whose end product, pyruvate, enters the mitochondria.
These events are thought to raise the [ATP]/[ADP] ratio, a
raise which closes ATP-sensitive potassium (KATP) chan-
nels in the cell membrane (Corkey et al., 1988). The result-
ingmembrane depolarization opens voltage sensitive calcium
(CaV) channels, resulting in an increased cytosolic calcium
concentration (Hellman et al., 1994). Such an increase, in
turn, is well correlated with insulin secretion from secretory
vesicles (Newgard and McGarry, 1995; Jonas et al., 1998).
A distinguishing feature of the secretory machinery is that
insulin is secreted in a pulsatory manner with a period on the
order of minutes (Lang et al., 1979). Notably, these
oscillations are lost in type II diabetes (Polonsky et al.,
1988). Membrane potential exhibits oscillations in the form
of bursts, with periods on the order of minutes as well as
faster burst patterns with periods in the order of seconds (Liu
et al., 1998). These bursts, in turn, are synchronized with
calcium entry into the cell (Dryselius et al., 1999).
Due to the complexity of this system, mathematical
modeling and numerical simulation is necessary to enable
a compact representation of the current knowledge and as
a tool to make meaningful quantitative predictions guiding
future experimental studies. Thus, the b-cell has attracted the
attention of theoretical investigators, who have suggested
several mathematical models explaining the faster bursting
pattern of b-cells (Sherman, 1996; Chay, 1997). Regarding
the slower oscillations, which due to the period similarity
and correlation with the insulin secretion are considered to be
crucial, an increasing amount of experimental data suggests
that they are the result of an oscillatory glycolysis. Ex-
perimental data supporting this theory include coordinated
oscillations in the [ATP]/[ADP] ratio, glucose-6-phosphate
(G6P) concentration, calcium concentration, and insulin se-
cretion (Nilsson et al., 1996; Deeney et al., 2001), as well as
calcium-independent oscillatory oxygen consumption
(Porterﬁeld et al., 2000). There is thus a need for modeling
studies of this area of b-cell biochemistry. We here suggest
a theoretical model of glycolytic oscillations in the b-cell
and present some predictions and conclusions based on this
model concerning the control of the occurrence and fre-
quency of oscillations.
The third enzyme of the glycolysis, phosphofructokinase
(PFK), has for a long time been known to cause oscillations
in the glycolysis in yeast and muscle (Goldbeter and Caplan,
1976; Hess, 1997). There are several indications that it is also
playing a role for the occurrence of oscillations in b-cell
glycolysis as well (Tornheim, 1997). PFK has also from
a clinical perspective been shown to be crucial for normal
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insulin secretion (Ristow et al., 1999). Given the currently
available data on glycolytic enzymes in the pancreatic b-cell,
we construct a minimal model coupling glucose to the PFK
catalyzed reaction.
The earliest model of oscillatory PFK dynamics is due to
Higgins (1964), who explained glycolytic oscillations in
yeast with the activation of PFK by one of its products,
fructose-1,6-bisphosphate (FBP). The model of Goldbeter
and Lefever (1972), also concerning yeast glycolysis, fo-
cused on the activation by the other product, ADP. As ex-
perimental data later accumulated, it became clear that
glycolytic oscillations in muscle primarily depend on PFK
activation by FBP (Tornheim and Lowenstein, 1975;
Tornheim, 1988). More recently, Yaney et al. (1995)
demonstrated that pancreatic PFK to a great deal is
comprised by the muscle isozyme, and also for the ﬁrst time
directly demonstrated the activation of pancreatic PFK by
FBP. Consequently, we will here focus on this mechanism.
Previous models of b-cell glycolysis have mainly focused
on steady-state analysis. Achs et al. (1991) constructed a very
detailed model, consequently more difﬁcult to validate,
while other workers (Sweet and Matschinsky, 1995; Sweet
et al., 1996, 1997) created a simpler core model focused on
the regulatory properties of glucokinase, the ﬁrst enzyme in
the glycolytic pathway in b-cells.
In this study we propose the ﬁrst model of glycolytic
oscillations in the b-cell that we are aware of, although
models of muscle glycolysis with emphasis on oscillatory
behavior based on PFK dynamics exist (Tornheim, 1979;
Smolen, 1995) and are based on the same mechanism.
Methodologically, our study differs from these in the respect
that we especially address the factors which are presently
less known experimentally. We then analyze the qualitative
behavior of the model in terms of these factors, which
include concentrations of enzymes and some of the allosteric
regulatory properties of PFK. Two main aspects of the
qualitative behavior of the model are considered, the pa-
rameter ranges that produce oscillatory behavior, and the
frequency of oscillations and control thereof.
We will emphasize the use of an operationally well-
deﬁned mathematical formulation of the model, meaning
that the model parameters reﬂect the degrees of freedom
biochemists observe in an as high degree as possible. This is
important to validate the model in terms of experimental
uncertainties.
METHODS AND MODEL
Our analysis concerns up to six biochemical reactions, as illustrated in Fig. 1.
Cytosolic glucose (Glc) is phosphorylated in a reaction catalyzed by
glucokinase (GK), resulting in the formation of G6P. G6P is converted to
fructose 6-phosphate (F6P) in the reaction catalyzed by glucose-6-phosphate
isomerase (GPI), followed by the PFK reaction which phosphorylates F6P to
form FBP. Notable about this reaction is the autocatalysis mentioned in the
introduction; FBP is an activator of PFK. FBP is removed through the
fructose-bisphosphate aldolase (FBA) catalyzed reaction which produces
dihydroxyacetone-phosphate (DHAP) and glyceraldehyde-3-phosphate
(G3P). DHAP is converted to G3P by triose-phosphate isomerase (TPI).
Finally, G3P is removed by glyceraldehyde-3-phosphate dehydrogenase
(GAPD). The primary data source on the activities of the different glycolytic
enzymes in the b-cell are the papers by Trus et al. (1981) and Shimizu et al.
(1988). To obtain a manageable model, we apply the method of separation of
timescales and consider the reactants of enzymes displaying high activity to
be maintained at an approximate equilibrium. Thus, we consider the GPI and
TPI reactions as an equilibria. The enzymes of the lower part of the
glycolysis all exhibit an activity at least an order of magnitude greater than
GK, PFK, and FBA (Trus et al., 1981; Shimizu et al., 1988). A possible
exception is GAPD, whose activity was measured in the backward direction
by Shimizu et al. (1988). The backward activity was found to be 10 times
greater than that of FBA, but the forward activity may be as low as 10 times
lower than the backward activity (Velick and Furﬁne, 1963). However, Trus
et al. (1981) found the forward GAPD activity to be almost 10 times greater
than that of PFK and 400 times higher than that of GK.
The main analysis is made using a basic model which is truncated after
FBA, and thus assumes the results of Trus et al. (1981) to hold. A more
thorough analysis of the removal of FBP demands inclusion of GAPD. This
is achieved with an extended model.
The GK and PFK reactions are at physiological conditions practically
irreversible and are here considered as such. Adenine nucleotides were
omitted from the model since the dynamics of the processes generating and
consuming them are poorly understood, and since experimental data
(Tornheim and Lowenstein, 1975; Tornheim, 1988) suggest that FBP-
dependent activation of PFK is the primary positive feedback loop
generating oscillations, although the activator AMP in these experiments
had to be present in order for FBP to activate PFK.
We formulate the basic model in terms of two dimensionless variables,
s ¼ ½F6P=SPFK0:5 and p ¼ ½FBP=S FBA0:5 . The parameters S PFK0:5 and SFBA0:5
represent the half-activation points for PFK (in the absence of any allosteric
modiﬁer) and FBA respectively. The GPI equilibrium has an equilibrium
FIGURE 1 Schematic representation of the model. The ﬂuxes over the
enzyme catalyzed reactions are denoted v. The dashed arrow represents the
allosteric activation of PFK by FBP. The basic model is truncated after FBA,
whereas the extended model takes all reactions into account.
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constant K GPIeq ¼ ½F6P=½G6P, and when introducing f ¼ KGPIeq =ð11K GPIeq Þ
the model can be written as
ds
dt
¼ f
S
PFK
0:5
ðvGK  vPFKÞ
dp
dt
¼ 1
S
FBA
0:5
ðvPFK  vFBAÞ; (1)
where the ﬂuxes v over the different enzymatic reactions are deﬁned in Fig. 1.
The extended model incorporates the TPI and GAPD reactions. The TPI
reaction exhibits a very large limiting rate and is here considered as an
equilibrium with equilibrium constant Keq
TPI. The extended model is then
written as
ds
dt
¼ f
S
PFK
0:5
ðvGK  vPFKÞ
dp
dt
¼ 1
S
FBA
0:5
ðvPFK  vFBAÞ
dr
dt
¼ g
S
GAPD
0:5
ð2vFBA  vGAPDÞ; (2)
where r ¼ ½G3P=S GAPD0:5 and g ¼ KTPIeq =ð1 1 KTPIeq Þ. S GAPD0:5 is the half-
activation point (or Michaelis constant) of GAPD with respect to G3P.
The main analysis of the glycolytic oscillator is performed on the basic
model. The extended model is used when analyzing the control over the
removal of FBP, this control being exerted both by FBA and by GAPD. In
the limiting case, when VGAPD  VFBA (as suggested by Trus et al. (1981)),
the basic model applies also here. All computations were made using the
program XPPAUT (http://www.math.pitt.edu/;bard/xpp/xpp.html).
Rate equations
GK
Glucose phosphorylation is in b-cells performed mainly by glucokinase
(hexokinase D) (Schuit et al., 1999). The reaction may at physiological
conditions be considered to be irreversible and also saturated with respect to
MgATP because of the low half-activation point with respect to this
substrate (Takeda et al., 1993). The ﬂux-concentration curve of GK is
slightly sigmoidal, and vGK is modeled with a Hill equation,
vGK ¼ VGKð½Glc=S
GK
0:5 ÞhGK
11 ð½Glc=SGK0:5 ÞhGK
; (3)
where SGK0:5 is the half-activation point of GK with respect to glucose, and
where hGK is the Hill coefﬁcient.
PFK
We assume that PFK with respect to its substrates, F6P and MgATP, follows
rapid equilibrium random bimolecular kinetics (Merry and Britton, 1985).
The enzyme may at physiological conditions be considered to be fully
saturated with respect to MgATP (Bosca et al., 1985).
Mammalian M-type PFK exhibits sigmoidal kinetics toward F6P. The
allosteric modiﬁer FBP exerts its inﬂuence by displacing the effective value
of the half-activation point toward lower F6P concentrations, whereas the
limiting rate (reaction rate approached upon addition of excess F6P) seems
to remain constant regardless of FBP concentration (Uyeda, 1979). We may
operationally deﬁne a parameter b as the factor by which the half-activation
point gets multiplied in the limiting case of addition of excess FBP (see Fig.
2 a). Further, some experiments suggest the Hill coefﬁcient is lowered by
FBP (Bloxham and Lardy, 1973; Uyeda, 1979; Otto et al., 1977), although
this effect is not apparent in other studies (Tornheim and Lowenstein, 1976).
The most frequent way of describing PFK kinetics has been to use some
kind of Monod-Wyman-Changeux (MWC) rate equation (Blangy et al.,
1968; Goldbeter and Lefever, 1972; Otto et al., 1977; Venieratos and
Goldbeter, 1979; Pettigrew and Frieden, 1979; Termonia and Ross, 1981).
However, there are problems with this approach when applied to mammalian
M-type PFK, directly evident by a lack of ability of the MWC model to ﬁt
experimental data (Smolen, 1995). Furthermore, it has been argued from
a mechanistic perspective that M-type PFK exists in at least three different
states in contrast to the two states of theMWCmodel (Kemp and Foe, 1983).
In the MWC model, the limiting rate, Hill coefﬁcient, and b are interrelated
in a complex manner through the model parameters and cannot be varied
independently (Goldbeter, 1976). This may account for the difﬁculty of
ﬁnding a parameter set accounting for experimentally observed kinetic
behavior.
Instead, we use a phenomenological Hill-type equation extended to
account for allosteric modiﬁers (Hofmeyr and Cornish-Bowden, 1997). An
advantage with this equation is that among its parameters we ﬁnd precisely
the operationally well-deﬁned entities discussed above; the limiting rate, Hill
coefﬁcient, and b may thus be varied independently. The rate equation is
written
vPFK ¼ VPFKs
hPFK
s
hPFK 1
11 ðqpÞhFBP
11aðqpÞhFBP
; (4)
FIGURE 2 (a) Flux-concentration curves of normalized PFK ﬂux and
F6P. The different curves correspond to different FBP concentrations. The
half-activation point is multiplied by a factor b=a ¼ b ¼ a1=hPFK upon the
presence of excess FBP. (b) Flux-concentration curves of normalized PFK
ﬂux and the allosteric activator FBP, with s¼ 0.25. The two different curves
correspond to the two different estimates of X0.5.
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where VPFK is the limiting rate, hPFK is the Hill coefﬁcient, s ¼ ½F6P=SPFK0:5
and p ¼ ½FBP=SFBA0:5  SPFK0:5 is the half-activating point when no modiﬁer is
present, and a ¼ bhPFK . In addition, q ¼ SFBA0:5 =X0:5, where X0.5 is
a parameter which may be interpreted as being proportional to the
dissociation constant for PFK and the activator FBP, and hFBP determines
the sigmoidicity of the allosteric modiﬁer effect. We propose the following
operational deﬁnition of X0.5. Provided that s[0, at the point where [FBP]
¼ X0.5, and thus qp ¼ 1, the relation
vPFK
v
ðsÞ
PFK
¼
s
hPFK 1
1
a
s
hPFK 1
2
11a
(5)
holds, where vPFK
(s) is the limiting rate at the particular value of s
considered, obtained when p ! ‘. This is easily veriﬁed; Eq. 5 is the ratio
between Eq. 4 with qp ¼ 1 and the limit of the same equation when p! ‘.
Note that Eq. 5 is completely independent of hFBP.
A potential drawback of Eq. 4 is that it does not account for the possible
decrease in sigmoidicity at high FBP concentrations. This effect may be
simulated by replacing hPFK with an effective value hPFK* depending on
FBP:
h

PFK ¼ hPFK  ðhPFK  hactÞ
qp
11 qp
; (6)
where hact represents the Hill coefﬁcient in the limiting case of excess FBP.
The factor qp=ð11qpÞ implies a hyperbolic dependence on FBP, an
assumption made in the absence of detailed experimental data on the
dependence of hPFK* on FBP. Equation 5 assumes a slightly different form
with hPFK* depending on FBP; s
hPFK is evaluated when qp¼ 1, the term 1=a
becomes sh

PFK jqp¼1=ðash

PFK Þjp!‘ and in the second term in the de-
nominator, a is evaluated with qp ¼ 1.
The study of the kinetic properties of PFK is further complicated by the
fact that the active form of PFK is a tetramer, though the enzyme is present
also as a monomer, dimer, as well as octamer and/or hexadecamer (Cai et al.,
1997). The tetramer is considered to be the most active oligomer (Rais et al.,
2000) because of a greater afﬁnity toward F6P, but the effects of enzyme
concentration on the equilibrium between different oligomers should be
considered. The physiological PFK concentration is in the order of 0.1–1
mg/ml (Trus et al., 1981; Shimizu et al., 1988). At this concentration PFK
mainly exists in a rapid equilibrium between tetramer and octamer (Cai et al.,
1997). A simple approximative relation between VPFK and S
PFK
0:5 , discussed
in detail in the appendix, is then
S
PFK
0:5 ¼
1
4
1
2VPFK
kcatKPFK
 1=2
1
1
2
K
1
T 1K
1
O
1
4
1
2VPFK
kcatKPFK
 1=2
 1
2
 ! ; (7)
where KT and KO are the S
PFK
0:5 values of pure tetramer and octamer,
respectively, and where KPFK is the equilibrium constant of the rapid
equilibrium between tetramer and octamer. The parameter kcat is a standard
catalytic constant such that VPFK ¼ kcatEPFK where EPFK is the enzyme
concentration. Because of the simplifying assumption that PFK only exists
in tetrameric and octameric form, Eq. 7 should be viewed as reﬂecting
a qualitative relationship rather than an exact quantitative one. As shown
in the appendix, when the tetramer concentration equals that of the
octamer,
kcatKPFK ¼ VPFK=3; (8)
a relation useful for the estimation of kcatKPFK.
That the effective value SPFK0:5 indeed varies with enzyme concentration
has been conﬁrmed (Bosca et al., 1985), albeit in a study where the enzyme
concentration was increased from ;1% to 100% of physiological
concentration, resulting in a decrease of SPFK0:5 , not surprisingly since the
enzyme at the lower concentration exists mainly as monomer or dimer.
FBA
The basic model is truncated after FBA, and the ﬂux over the FBA catalyzed
reaction is modeled using a Michaelis-Menten equation,
vFBA ¼ VFBAp
11p
: (9)
The extended model involves a reversible rate equation for FBA. This
equation is based on a sequential mechanism of the FBA reaction, where
G3P is released before DHAP (Horecker et al., 1972), and was derived using
the methodology outlined e.g. by Hofmeyr and Cornish-Bowden (1997),
where quasi-equilibrium between the different enzyme-ligand complexes is
assumed. The resulting rate equation is written
vFBA ¼
VFBAp 1 prr
2
pK
FBA
eq
 !
11p1 rr1 prr2
; (10)
where KFBAeq is the equilibrium constant of the FBA reaction. Introducing
PFBA0:5 as the half-saturating point of the backward reaction with regard to
G3P and QFBA0:5 as the same parameter with regard to DHAP, one obtains
p ¼ SGAPD0:5 =PFBA0:5 and r ¼ SGAPD0:5 =ðQFBA0:5 3KTPIeq ).
GAPD
GAPD converts G3P, NAD1 and Pi to 1,3-bisphospho-glycerate and
NADH. We make the approximation of constant NAD1, NADH, and Pi
concentrations, and since the extended model is truncated after the GAPD
reaction, we describe the GAPD reaction with a simple irreversible
Michaelis-Menten equation:
vGAPD ¼ VGAPDr
11 r
: (11)
Parameter estimations
We will use a standard parameter set, presented in Table 1, as a basis for the
further investigations. These values should be assumed to apply when
nothing else is stated. Because of experimental uncertainties and the variable
chemical milieu in the cytosol, the model is analyzed in terms of ranges of
many of the parameters.
GK
The kinetic behavior of GK is comparably well-characterized, and we use
a SGK0:5 value of 8 mM and a Hill coefﬁcient of 1.7 (Gidh-Jain et al., 1993;
Ca´rdenas, 1997; Matschinsky et al., 1998).
PFK
In addition to FBP, mammalian M-type PFK also has well-characterized
activating sites for AMP, citrate and 3-P-glyceric acid, and an inhibitory site
for ATP (Kemp and Foe, 1983). These effectors affect the apparent value of
the parameter SPFK0:5 , which needs to be taken into account when evaluating
experimental data, since at least some amount of ATP and AMP usually is
present in the experimental setting. Also, as discussed above, the apparent
SPFK0:5 value varies with enzyme concentration (Bosca et al., 1985) and pH
(Pettigrew and Frieden, 1979) and is also impossible to obtain directly, since
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both the substrate ATP and the product FBP are also allosteric modiﬁers.
These difﬁculties lead us to treat SPFK0:5 as a variable, in the sense that we
evaluate different scenarios using different (ﬁxed or varying with VPFK)
values of SPFK0:5 . Nevertheless, we have to conﬁne the values used to a range
matching experimentally observed data.
Various experiments (Bosca et al., 1985; Foe and Kemp, 1985; Otto et al.,
1977; Tornheim and Lowenstein, 1976; Meienhofer et al., 1980) lead us to
estimate a range of 1–8 mM for SPFK0:5 . In the simulations where Eq. 7 is
applied, we use a value of 2 mM for KT and we make the arbitrary
assumption that KO ¼ 15KT, which leads to effective SPFK0:5 values of ;3–7
mM in the ranges of VPFK investigated, in rough agreement with data
obtained from in vitro experiments on PFK at physiological concentration of
the enzyme (Bosca et al., 1985). We point out that the arbitrary choice for KO
does not inﬂuence the model very much, in contrast to the parameter KT. The
parameter product kcatKPFK is estimated from the experiments of Cai et al.
(1997). In that study, the concentrations of tetramer equaled that of octamer
at a PFK concentration of ;1.5 mg/ml. With a speciﬁc activity of PFK
of ;200 mmol/(mg min) (Uyeda, 1979), VPFK ¼ 100 mmol/(gdwmin)
corresponds to a PFK concentration of;0.2 mg/ml. This leads us to assume
in our model that the tetramer and octamer concentrations are equal when
VPFK ¼ 700 mmol/(gdw min), and we thus obtain kcatKPFK ¼ 233 mmol/(gdw
min) using Eq. 8.
We estimate hPFK to be 2.5 (Tornheim and Lowenstein, 1976; Bosca et al.,
1985; Meienhofer et al., 1980). The Hill coefﬁcient hPFK is assumed to vary
with FBP concentration unless otherwise stated, and we set hact to 1. The
value of b appears to be ;0.2 (Tornheim and Lowenstein, 1976), so that
a ¼ 5hPFK . The parameters X0.5 and hFBP may be estimated from the
experiments in which the activation of b-cell PFK by FBP has been
demonstrated (Yaney et al., 1995). We estimate X0.5 from a plot of vPFK
versus [FBP] in that study by use of Eq. 5. In this way, we obtain a value of
;20 mM for X0.5 for both constant and variable hPFK. A drawback with this
data is that its resolution is rather low, which is why we will also consider
other experimental data on M-type PFK. Using the same method, we obtain
a value of ;10 mM from the studies of Foe et al. (1983) and Tornheim
(1985). Note that the available experimental data only allow a crude
estimation of the parameter.We will unless otherwise indicated use the lower
value, but certainly investigate the effects of the higher value. The FBP-vPFK
curve appears hyperbolic in the experiments on b-cell PFK (Yaney et al.,
1995), which would suggest a value near 1 for hFBP. On the other hand, again
the other experimental studies on M-type PFK (Foe et al., 1983; Tornheim,
1985) suggest otherwise, implying a sigmoid shaped relationship. We will
unless otherwise stated set hFBP to 2.5, but also study the model behavior
when hFBP¼ 1. Fig. 2 a shows a plot of normalized PFK activity versus F6P
concentration using our PFK rate equation with varying hPFK at three
different FBP concentrations. This plot represents experimental results of
Tornheim and Lowenstein (1976) and Bosca et al. (1985); it assumes an
effective SPFK0:5 value of 4 mM approaching 0.8 mM upon addition of the
activator FBP. Fig. 2 b shows a plot of normalized PFK activity versus FBP
concentration at the two different X0.5 values 10 mM and 20 mM (with s ¼
0.25 and hFBP ¼ 2.5). This plot represents experimental results of Foe et al.
(1983); Tornheim (1985) and of Yaney et al. (1995), respectively.
FBA
FBA exists in man in three isozyme forms; A (muscle), B (liver), and C
(brain), of which at least type B and C (the latter which has a larger SFBA0:5
value) are present in b-cells (Inagaki et al., 1988; Wang et al., 2000). The
effective value of SFBA0:5 in b-cells is therefore estimated to be in the range of
5–15 mM based on experimental measurements (Horecker et al., 1972;
Kusakabe et al., 1994). For the reversible rate equation, we used parameter
values as follows: KFBAeq ¼ 0:1mM (Veech et al., 1969), PFBA0:5 ¼ 0:5mM,
and QFBA0:5 ¼ 0:275mM (Horecker et al., 1972), so that p ¼ 0.01 and r ¼ 0.4
(obtained with the value of SGAPD0:5 estimated below).
GAPD
We considered the value of the parameter SGAPD0:5 to lie between 2.5 mM
(Velick and Furﬁne, 1963) and 9 mM (MacDonald, 1989). We use the value
SGAPD0:5 ¼ 5mM in the extended model.
Other parameters
The equilibrium constant KGPIeq of the GPI catalyzed reaction is 0.3 (Alberty,
2000), and the equilibrium constant of the TPI catalyzed reaction in the
backward direction (G3P converted to DHAP) is 22 (Veech et al., 1969), so
that KTPIeq ¼ 1=22. Measurements of the three limiting rates V of our model,
which are proportional to the enzyme concentrations and thus exhibit large
natural variations, are subject to considerable experimental uncertainties
(Albe et al., 1990). The limiting rates are therefore allowed to vary over large
ranges guided by experimental data (Trus et al., 1981; Shimizu et al., 1988).
The default values are listed in Table 1. Throughout this work, the unit for
the limiting rates is mmol/(gdw min), (dw standing for weight of dry tissue)
which was used to simplify comparisons with experimental data. When
converting this unit to M/s for the numerical calculations, an assumption of
a dry weight:wet weight ratio of 1:4 was made based on experimental data
(Erecinska et al., 1992).
Phase plane analysis
Additional insights may be gained by means of a phase plane analysis of the
basic model. A similar analysis of the PFK reaction in yeast has been made
previously (Venieratos and Goldbeter, 1979). The dynamical system is
characterized by the ﬁxpoint at which the derivatives in Eq. 1 are both zero.
If all eigenvalues of the Jacobian of Eq. 1 have negative real part, the ﬁxpoint
is stable, and the system evolves toward this steady state over time. If the
Jacobian has eigenvalues with positive real part, the ﬁxpoint is unstable, and
the system may enter a limit cycle, an oscillatory stationary mode. As was
pointed out earlier (Venieratos and Goldbeter, 1979) and as shown in the
appendix, the ﬁxpoint is unstable if the condition
TABLE 1 Default values for the model parameters
SGK0:5 8 mM
SPFK0:5 4 mM
X0.5 10 mM
SFBA0:5 5 mM
PFBA0:5 0.5 mM
QFBA0:5 0.275 mM
SGAPD0:5 5 mM
KGPIeq 0.3
KFBAeq 0.1 mM
KTPIeq 1/22
kcatKPFK 233 mmol/(gdw min)
hGK 1.7
hPFK 2.5
hact 1
hFBP 2.5
a 5h

PFK
VGK 10 mmol/(gdw min)
VPFK 100 mmol/(gdw min)
VFBA 25 mmol/(gdw min)
VGAPD 250 mmol/(gdw min)
These values are used throughout the study if nothing else is stated. hPFK* is
the effective Hill coefﬁcient as deﬁned by Eq. 6. Enzyme activities are
given in units of mmol/(gdw min), dw standing for dry weight. This unit is
used to simplify comparisons with other models and experimental data.
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ds
dp
\  f 3 S
FBA
0:5
S
PFK
0:5
(12)
is fulﬁlled at the ﬁxpoint for the curve in the phase plane where dp=dt ¼ 0,
hereafter referred to as the p nullcline (the s nullcline is deﬁned in the same
way).
RESULTS
Numerical integration
Numerical integration of the basic model (Eq. 1) shows that
the variables of the system may exhibit continuous os-
cillations. We start with the standard parameter set (with a
stimulatory glucose concentration of 10 mM) and the re-
sults are shown in Fig. 3 a, where the time course of the
concentrations of F6P and FBP is shown. The time scale of
the oscillations roughly ﬁts what is known experimentally
from pancreatic b-cells of slow oscillations thought to have
metabolic origin (Hellman et al., 1994; Tornheim, 1997).
Further, the shapes of the curves ﬁt with data obtained from
muscle cell extracts, with regard to the sawtooth shape of the
F6P curve and the pulsatile FBP curve (Tornheim, 1988).
The average F6P concentration is in the order of 10 times
higher than available data on b-cells (Trus et al., 1980). A
more detailed model, including adenine nucleotide modula-
tion of PFK, might give results more closely resembling
these experimental data, for example by reducing the
effective value of SPFK0:5 . The FBP concentration immediately
after the pulse is very low, as shown in Fig. 3 b, which is
a magniﬁcation of a part of the simulation. Decreasing SPFK0:5
to 2 mM markedly decreases the oscillation period (Fig. 3 c),
and the amplitudes of both the F6P and FBP oscillations are
seen to be halved. We conclude that SPFK0:5 has a crucial
inﬂuence on the oscillatory behavior.
Phase plane analysis
One way to illustrate these events is to employ phase plane
analysis. As stated in Eq. 12, the p nullcline has to have
sufﬁciently negative slope in the (p, s) plane in order for
the steady state to become unstable. We have plotted the
nullclines in the (p, s) plane in Fig. 4 a for a nonstimulatory
and a stimulatory glucose concentration. The stable limit
cycle in the ﬁgure emerges when the glucose concentration
is raised to a stimulatory concentration, where we can see
that the p nullcline has a negative slope at the steady state.
The negative slope of the p nullcline is caused by the
autocatalysis of PFK. We remark here that the nullclines are
completely independent of SPFK0:5 , meaning that this parameter
will not have any inﬂuence on the location of the threshold of
oscillations in the (p, s) plane. Fig. 4 a was produced using
a variable Hill coefﬁcient hPFK* (cf. Eq. 6). Instead using
a ﬁxed value of 2.5 produced small changes in the nullclines
and the limit cycle. However, when using both a ﬁxed hPFK
and a low Hill coefﬁcient hFBP of the allosteric activation by
FBP (hFBP ¼ 1) as suggested by experiments on b-cell PFK,
the amplitude of oscillation is severely diminished, which
can be seen in Fig. 4 b. Keeping this low hFBP value but
FIGURE 3 (a) Oscillations in the glycolysis as
modeled by Eq. 1, obtained by numerical in-
tegration. The dotted line represents F6P, while the
solid line represents FBP. The curve shapes and
oscillation period resembles experimental data
obtained from muscle extracts. Parameter values
are listed in Table 1, glucose concentration was set
to the stimulatory level 10 mM. (b) Magniﬁcation of
a part of panel a. The F6P concentration decreases to
a very low level during a brief part of the oscillation
period. Available experimental data are of too low
resolution to allow comparison to this result. (c)
Decreasing SPFK0:5 to 2 mM halves the oscillation
period, as well as the amplitudes of the oscillations.
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reinstating the variable hPFK* counteracts this modulation of
the oscillations (Fig. 4 b, dotted line). Thus, with a variable
hPFK*, the system is more robust to changes in hFBP, with
oscillations of signiﬁcant amplitude occurring also with
a hFBP value of 1.
Bifurcation analysis
More generally, one may investigate the model for a range of
glucose concentrations while keeping the rest of the model
parameters constant. This has been done by means of
bifurcation analysis (Fig. 5 a). At subthreshold (0–9.7 mM)
glucose concentrations, the system enters a steady state,
which at the threshold becomes unstable through a supercrit-
ical Hopf bifurcation, where a stable limit cycle emerges.
Because of glucose saturation, a more complete picture is
obtained if instead varying VGK, keeping [Glc] ﬁxed at 10
mM (Fig. 5 b). This analysis reveals a second (subcritical)
Hopf bifurcation at VGK  38 mmol/(gdw min), and the
steady state again becomes stable at higher values of vGK.
Because of the subcriticality, there is an interval in which the
stable steady state coexists with the stable limit cycle, a result
which also was reported in an earlier study of PFK dynamics
(Venieratos and Goldbeter, 1979). The period of oscillation
is shown in Fig. 5 c and is, when increasing VGK, seen to
initially decrease after the supercritical Hopf bifurcation is
passed. At higher values of VGK the period instead increases
until the subcritical Hopf bifurcation is reached. Indeed,
Lenzen et al. (2000) observed a signiﬁcantly increased os-
cillation period of slow calcium oscillations as [Glc] was in-
creased from 10 mM to 20 mM, providing indirect support
for this result, since vGK is an increasing function of both
VGK and [Glc], directly proportional in the former case and
slightly sigmoidal with VGK as the upper limit in the latter
case. However, Bergsten and Hellman (1993) and Cunning-
ham et al. (1996) observed no such period increase when
increasing [Glc]. This is not necessarily contradicting our
results, since 5 c exhibits a plateau where the oscillation
period is relatively insensitive to VGK. If VGK lies at this
plateau, the oscillation period may appear independent of
[Glc].
The relation between VGK, [Glc], and the bifurcations
was also investigated, and the results are shown in Fig. 5 d.
Noteworthy is that the glucose concentration threshold for
oscillations (the supercritical Hopf bifurcation) does not
change much with VGK in the higher region of VGK values.
On the other hand, the opposite is true at lower VGK
values, where the threshold strongly varies with the
parameter. This may provide one explanation for the ex-
perimentally observed phenomenon that moderate over-
expression of GK potentiates insulin secretion and lowers
the glucose threshold, whereas excessive overexpression
does not make any further difference (Wang and Iynedjian,
1997).
In the same manner, we have analyzed the model in terms
of parameters related to PFK. In the following, we will relate
the different parameters analyzed to VGK, which is directly
proportional to vGK, while holding [Glc] ﬁxed at 10 mM. The
reason for this is of course that vGK is readily controlled
experimentally by varying the glucose concentration. A bi-
furcation diagram relating VPFK, VGK and the bifurcations
is shown in Fig. 6 a. The lesson to be learned here is basically
that the bifurcation points do not vary with VPFK, except for
very low values of the parameter. Variation of VPFK does
however change the period of oscillations, which decreases
with increasing values of the parameter as can be seen in Fig.
6 c. Here, SPFK0:5 was set to the intermediate value of 3 mM, to
facilitate comparison with the curved obtained when
applying Eq. 7 as described below. Variation of SPFK0:5
produces the opposite result: the oscillation period increases
with increasing parameter values (Fig. 6 b). Noteworthy is
that the relation appears perfectly linear, and again we
consider Fig. 4 a and the limit cycle in the phase plane (p,
s). The location of the nullclines in phase plane is
FIGURE 4 (a) Phase plane analysis of the model. The
solid line with ﬁlled circles is the p nullcline. The dotted
line is the s nullcline at a subthreshold glucose con-
centration of 5 mM. This nullcline intersects the p nullcline
at a point where the slope of the latter is positive and this
point is thus a stable steady state. The dashed line is the s
nullcline at a superthreshold glucose concentration of 15
mM and this nullcline intersects the p nullcline at a point
where the slope of the latter is sufﬁciently negative for the
inequality (12) to hold, making the steady state unstable. A
stable limit cycle then exists, in the diagram depicted as the
closed thicker solid line. The arrow indicates the direction
by which the limit cycle is transversed over time. Parameter
values are listed in Table 1. (b) The Hill coefﬁcient of the
allosteric activation of PFK by FBP is in this diagram set to
1, parameters are otherwise the same as in panel (a). The dashed line is the p nullcline and the solid line is the corresponding limit cycle appearing at
a superthreshold glucose concentration of 15 mM (for clarity, the s nullclines are not included in this diagram). When, in addition, the Hill coefﬁcient of the
substrate F6P is ﬁxed (i.e., hact ¼ 2.5), the amplitude of oscillations is signiﬁcantly lowered. This is evident from the dotted limit cycle and corresponding p
nullcline drawn as a solid line with ﬁlled circles.
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completely independent of SPFK0:5 . During the phase where p
is low, ds=dt  dp=dt. The limit cycle closely follows the
p nullcline. The time course of the system is here one-
dimensional in the sense that almost only ds=dt determines
how quickly the limit cycle is followed, and ds=dt is exactly
inversely proportional to SPFK0:5 , cf. Eq. 1. The greatest part of
one oscillation period is spent in this phase. Also in the phase
when p is high, ds=dt is almost independent of p because
the allosteric modiﬁer effect exhibits saturation. Thus here
too, the value of ds=dt is dominant in determining the speed
by which the limit cycle is followed in the downwards s
direction. The horizontal phases of the limit cycle in Fig. 4
a are followed very fast. Thus, oscillation period is almost
linearly proportional to SPFK0:5 .
When applying the relation given by Eq. 7 between VPFK
and SPFK0:5 , it becomes clear that an increase in S
PFK
0:5 mediated
by an increase in VPFK stabilizes the system with regard to
variations in PFK concentration; the variation in oscillation
period with VPFK is less marked (Fig. 6 c). Finally, we
consider the parameter X0.5. The bifurcation diagram of Fig.
6 d reveals only a slight shift toward higher VGK values for
the oscillatory region as X0.5 increases from 10 to 20 mM.
Moreover, the doubling of this parameter does not produce
any marked change in oscillation period as is evident from
Fig. 5 c.
The two parameters related to FBA both exhibit
a signiﬁcant inﬂuence on the basic model. The bifurcation
diagram of Fig. 7 a shows that the bifurcation points are
shifted toward higher values of VGK as VFBA increases,
almost linearly. This leads us to propose that, when VGAPD
 VFBA, the system with regard to the thresholds con-
veniently would be characterized by the VGK/VFBA ratio. One
FIGURE 5 In all panels, unless stated otherwise,
parameters are as listed in table 1. (a) Bifurcation diagram
of the system which shows the general model behavior
over glucose concentrations in the range 1–30 mM. The
solid thick line represents a steady stable state, the dotted
line represents an unstable steady state. The thinner solid
lines represent the upper and lower extreme values of s of
the limit cycle, emerging from the Hopf bifurcation marked
with a square. The inset shows a magniﬁcation around the
Hopf bifurcation. (b) A more complete diagram is obtained
when letting VGK vary over the range 1–40 mmol/(gdw
min), keeping [Glc] ﬁxed at 10 mM. A second Hopf
bifurcation is revealed. The thin dotted lines represent an
unstable limit cycle. (c) The oscillation period varies with
VGK. The solid line was obtained with all parameters
except VGK as in Table 1; the dashed line was obtained
with X0.5 ¼ 20 mM. [Glc] was set to the stimulatory level
10 mM. (d) Bifurcation diagram relating the two Hopf
bifurcations to the glucose concentration and VGK. The
bifurcations are represented by the solid lines. Stable
oscillations occur when the two bifurcation parameters lie
within the shaded area. Note how the oscillatory glucose
region changes less with VGK for higher values of this
parameter.
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should note that FBA activity was experimentally found to
be higher than GK activity (Trus et al., 1981; Shimizu et al.,
1988) and that the regions of the diagram with higher values
of VFBA hence are more plausible. The oscillation period
drops dramatically as VFBA is increased near the ﬁrst
bifurcation point, but otherwise remains stable as the
parameter varies (not shown). On the other hand, the
oscillatory region is shifted toward lower values of VGK as
SFBA0:5 increases (Fig. 7 b), while the oscillation period
decreases (not shown). Thus, the basic model predicts that
FBA concentration, as well as that of GK and PFK, may play
an important role in determining the dynamics of the
glycolysis. This means that accurate measurements of the
parameter S0.5
FBA are necessary to gain a full characteriza-
tion of the oscillatory system.
Extended model
To obtain more general results to account for the possible
situation where VFBA and VGAPD are of similar magnitudes,
bifurcation analyses of the extended model involving VGK,
VFBA, and VGAPD were made. With VGAPD ¼ 250 mmol/(gdw
min), which is in the order of what Trus et al. (1981)
reported, the bifurcation diagram shown in Fig. 8 a with VGK
and VFBA as bifurcation parameters is obtained. Evidently,
VFBA has signiﬁcant control over the oscillatory region at
FIGURE 6 In all panels, unless stated otherwise,
parameters are as listed in Table 1 and [Glc] is set to the
stimulatory level 10 mM. (a) Bifurcation diagram relating
the limiting rates of GK and PFK to the Hopf bifurcations.
Note that the bifurcation points are almost independent of
VPFK except for low values of the parameter. (b) The
oscillation period varies linearly with SPFK0:5 . (c) The
oscillation period varies with VPFK. The solid line was
obtained using a ﬁxed value of 3 mM for SPFK0:5 . The dashed
line was obtained when applying Eq. (7), with KT ¼ 2 mM
and KO¼ 30 mM. This shows that the equilibrium between
PFK tetramer and octamer exerts a stabilizing effect on the
oscillation period with respect to variations in VPFK. (d )
Bifurcation diagram relating the limiting rate of GK to X0.5.
There is no dramatic effect on the bifurcation points as X0.5
is varied along its estimated range.
FIGURE 7 In both panels, unless stated otherwise,
parameters are as listed in Table 1 and [Glc] is set to the
stimulatory level 10 mM. (a) Bifurcation diagram relating
VFBA, VGK, and the bifurcation points, showing an almost
linear relationship. (b) Bifurcation diagram showing the
location of the bifurcation points with respect to VGK and
SFBA0:5 . The latter parameter is estimated to lie in the range
5–15 mM. The bifurcation points are displaced toward
lower VGK values as S
FBA
0:5 increases.
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lower values of the parameter, which is successively lost as
the parameter increases. Not surprisingly, VFBA and VGAPD
share control when their values are similar. A bifurcation
analysis with VGAPD as bifurcation parameter (Fig. 8 b)
reveals that VGAPD has moderate control over the oscillatory
region when VGAPD ¼ 10VFBA. As VGAPD is lowered, its
control increases. Thus, if the experimental values of
Shimizu et al. (1988) reﬂect reality, VGAPD does have
signiﬁcant control over the system. What about VFBA in this
case? Fig. 8 c shows a bifurcation diagram obtained with
VGAPD ¼ 35 mmol/(gdw min). One notices that VFBA has
almost no control at the operating point VFBA ¼ 25 mmol/
(gdw min). VFBA has to be signiﬁcantly lower than VGAPD in
order to gain control. On the other hand, with a fourfold
higher FBA activity VFBA ¼ 100 mmol/(gdw min), VGAPD is
in Fig. 8 d seen to have more control over the oscillatory
region (almost linear borders) than was the case with the
lower FBA activity.
DISCUSSION
Our model, based on kinetic data on the enzymes in the
upper part of the glycolysis in the pancreatic b-cell, predicts
an oscillatory behavior of b-cell glycolysis in a signiﬁcant
region of parameter space. The threshold glucose concen-
tration is in general found at 5–10 mM (Fig. 5 d ), which is
the same range as the threshold glucose concentration
experimentally seen to induce slow calcium oscillations (Liu
et al., 1996). However, the threshold depends on model
parameters, most notably the limiting rates V of the different
reactions, which are directly proportional to enzyme
concentrations. Here one should note that our model
suggests that control over different aspects of the behavior
of the initial steps in glycolysis is exerted by different
enzymes. The GK and FBA and/or GAPD concentrations
have a large inﬂuence on at which glucose concentrations
glycolytic oscillations occur. PFK concentration has little
control over this, but instead inﬂuences the frequency of
oscillations as seen in Fig. 6 c. These results point toward the
need for accurate quantitative data regarding these enzyme
concentrations to characterize the dynamics of glycolysis in
the pancreatic b-cell. The parameter SPFK0:5 has a well-deﬁned
control over oscillation period, the relationship being
essentially linear. This should be possible to test experimen-
tally, since the effective value SPFK0:5 may be altered by several
chemical agents.
Robustness of the model
Robustness is a feature of general importance for biological
systems. Thus, noting that the oscillation period of our
glycolytic oscillator is quite sensitive to PFK concentration
(Fig. 6 c, solid line), the question if there exists any
mechanism which counteracts this sensitivity is justiﬁable.
From this starting point, we observe that the sensitivity of the
oscillation period to PFK concentration is reduced if the
relation of Eq. 7 is applied, since the parameters VPFK
FIGURE 8 In all panels, unless stated otherwise,
parameters are as listed in Table 1 and [Glc] is set to the
stimulatory level 10 mM. (a) Bifurcation diagram showing
the dependence of the oscillatory region on VFBA for the
extended model. FBA exerts signiﬁcant control at lower
values of VFBA, but loses control as this parameter
increases. (b) This diagram shows the dependence of the
oscillatory region on VGAPD, which at higher values (an
order of magnitude greater than VFBA) has little control
over the oscillatory region. (c) This diagram is the same as
(a), except with VGAPD ¼ 35 mmol/(gdw min). FBA is seen
to have no signiﬁcant control over the oscillatory region
except at very low values of the parameter. (d ) This
diagram is the same as b, except with VFBA ¼ 100 mmol/
(gdw min). GAPD is seen to have signiﬁcant control over
the oscillatory region throughout the region of VGAPD
examined. We may draw the conclusion that GAPD has
most of the control when VFBA  VGAPD, but loses this
control in favor of FBA if VFBA is decreased to a level an
order of magnitude lower than VGAPD.
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and SPFK0:5 have opposite effects on the oscillation period, as
shown by our computations (Fig. 6 c, dashed line). The
glycolytic oscillation period is therefore stabilized through the
equilibrium between the tetramer and octamer forms of PFK.
The PFK activation by FBP appears hyperbolic in some
experiments (Yaney et al., 1995) and sigmoidal in others (Foe
et al., 1983; Tornheim, 1985). We found that the model is
robust in terms of the sensitivity to variation in this
sigmoidicity if the sigmoidicity of the ﬂux-concentration
relationship between F6P and vPFK decreases as FBP
concentration increases, as some experiments suggest (Blox-
ham and Lardy, 1973; Uyeda, 1979; Otto et al., 1977). This
decrease in hPFK would therefore stabilize oscillations if the
sigmoidicity of the PFK activation by FBP varies for instance
due to variations in the chemical environment.
GK as glucose sensor
GK has, through experiments and by virtue of methods
from metabolic control theory (MCT) been proposed to be
the primary control point of the glycolysis (Sweet and
Matschinsky, 1995; Matschinsky et al., 1998; Wang and
Iynedjian, 1997), the notion of control here being the relative
steady state glycolytic ﬂux change per relative enzyme
concentration change. In the experiments of Shimizu et al.
(1988), the ﬂux-concentration curve between glycolytic ﬂux
and glucose matches the ﬂux-concentration curve of GK
closely. This also applies to the present model. Since we
have approximated the GK reaction as being fully irrevers-
ible, GK alone determines the ﬂux through glycolysis at
steady state, or the average ﬂux over an oscillation period if
oscillations are present.
However, two control properties which standard MCT is
not applicable to in a straightforward manner, but which still
are of great importance for the insulin secretion system, are,
ﬁrst, the control over oscillation period and, second, the
control of the boundary of the onset of the Hopf bifurcation at
which a stable ﬁxpoint is replaced by an attractive limit cycle
as [Glc] is increased. In the situation where VGAPD  VFBA,
judging from the bifurcation diagram of Fig. 7 a, FBA as well
is seen to exert this type of control. Because of the almost
linear relations apparent fromFig. 7a,we propose that a sound
characteristic of the glucose sensing system in this case would
be the ratio VGK/VFBA. The analysis of the extended model
shows that as VGAPD approaches VFBA, GAPD gradually
overtakes control from FBA. In the casewhenVFBAVGAPD,
the ratio VGK/VGAPD would be a good characteristic (Fig. 8),
although the inﬂuence of product inhibition on GAPD should
be subject to further investigation since it to some degree
affects the control exerted by the enzyme.
It should be possible to investigate experimentally the
validity of the results of Fig. 7 a and Fig. 8. Speciﬁcally, it
would be desirable to obtain a better estimate of the op-
erating point of b-cells with regard to the parameters VGK,
VFBA, and VGAPD.
It is evident from Fig. 5 d that at higher values of VGK, the
effects of variations in this parameter become less important
both regarding oscillation period and the boundary of the
onset of oscillations. We may here speak of GK losing its
control strength at higher concentrations. Experimental data
which relate overexpression of b-cell GK to stimulus-
secretion coupling (Wang and Iynedjian, 1997) indirectly
support this result. The authors found that moderate
overexpression lowered the [Glc] level needed to reach
maximum insulin secretion, but that a further increased
overexpression failed to exert any additional effect.
In conclusion, this study shows that oscillations in the
glycolysis of pancreaticb-cell are plausible from a theoretical
perspective, given the current knowledge of b-cell bio-
chemistry.
We argue that equations with operationally well-deﬁned
parameters, such as those used in this study, are particularly
useful when performing systems level investigations. Here,
this is exempliﬁed by the straightforward incorporation of
biochemical reasoning about experimental uncertainties into
the model. Also, operationally well-deﬁned parameters make
it possible to directly connect biochemical observations to
emerging properties at the systems level. This is exempliﬁed
by the analyses in this work, where we were able to pinpoint
mechanisms involved in stabilizing the glycolytic oscillation
period.
There is a large step from the single PFK catalyzed
reaction to the entire glycolysis and the whole b-cell
biochemistry and furthermore to whole islet behavior. In
particular, the coupling of glycolytic oscillations to whole-
cell [ATP]/[ADP] ratio oscillations needs to be thoroughly
investigated. Adenine nucleotides are allosteric effectors of
PFK, and oscillations in their concentrations may modulate
the oscillatory behavior, even though they are not the
primary generators of oscillations. Nevertheless, experi-
ments have indicated a substantial contribution of PFK on b-
cell secretory function (Tornheim, 1997; Ristow et al., 1999)
and it is our belief that the understanding and stepwise
integration of smaller biochemical subsystems into larger
models can provide important insights into the global
behavior and dynamics in which these smaller, more local
subsystems may retain some of their qualitative behavior.
This means that this minimal model may provide important
initial insights into the stimulus-secretion machinery.
APPENDIX
Stability analysis of the PFK reaction
The basic model, as represented by Eq. 1, is reformulated as
ds
dt
¼ k1vGK  k1A
dp
dt
¼ k2A k2B; (A1)
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where
A ¼ vPFKðs;pÞ ¼ VPFKs
hPFK
s
hPFK 1
11 ðqpÞhFBP
11aðqpÞhFBP
;
and
B ¼ vFBAðpÞ ¼ VFBAp
11p
:
Here we have set k1 ¼ f=SPFK0:5 ,k2 ¼ 1=SFBA0:5 . Differentiation of the system
(Eq. A1) results in the Jacobian J:
J ¼ k1As k1Ap
k2As k2ðAp  BpÞ
 
;
where As ¼ @A=@s and so forth. According to the principle of linearized
stability, a ﬁxpoint of the system (Eq. A1) is unstable when at least one
eigenvalue of J has a positive real part at the ﬁxpoint. The eigenvalues l of J
are the solutions to the characteristic equation
l
21 ðk1As  k2ðAp  BpÞÞl1 k1k2AsBp ¼ 0: (A2)
Thus, a condition for a ﬁxpoint in order for it to be unstable is
k1As  k2ðAp  BpÞ\0: (A3)
To reformulate this condition in terms of the FBP nullcline in the phase
plane, we consider the differential of dp=dt:
d
dp
dt
 
¼ k2ðAs ds1 ðAp  BpÞdpÞ:
On the FBP nullcline (and on any contour on which dp=dt is constant),
dðdp=dtÞ ¼ 0, and thus
ds
dp
¼ Ap  Bp
As
: (A4)
Equations. A3 and A4 together give the condition
ds
dp
\  k1
k2
; (A-5)
for the FBP nullcline on the ﬁxpoint in order for the latter to be unstable,
which is the same condition as Eq. 12. Since the third term on the left side of
Eq. A2 always is positive (both A and B will always increase with respective
increase in s and p), the eigenvalues will, at the verge of instability where
the left side of Eq. A3 vanishes, be purely imaginary, which means that the
system here undergoes a Hopf bifurcation.
Apparent substrate dissociation constant of PFK
According to the derivation of the different types of Hill equations made by
Hofmeyr and Cornish-Bowden (1997), SPFK0:5 may be interpreted as being
proportional to a dissociation constant between F6P and PFK. Viewing PFK
as mainly existing as tetramer and octamer, we consider SPFK0:5 to effectively
behave as an apparent dissociation constant (which may only be
approximately true) and write
S
PFK
0:5 ¼
F6P3 ðT1 2OÞ
F6PT1 F6PO
(A6)
where T and O indicate the concentration of free enzyme in tetramer and
octamer conformation respectively, and where F6PT and F6PO denote the
concentrations of the two different substrate-enzyme complexes. F6P has
a dissociation constant with respect to each of the two oligomers. Denoting
these two constants as KT and KO, we have
F6PT ¼ F6P3 T
KT
F6PO ¼ F6P3 2O
KO
: (A7)
Equations A6 and A7 give the relation
S
PFK
0:5 ¼
11 2
O
T
K
1
T 1 2K
1
O
O
T
:
We make the assumption that the tetramer and octamer exist in an
equilibrium independent of substrate binding and thus consider the total
concentrations of tetramer and octamer and the corresponding apparent
equilibrium constant KPFK:
T
2
tot
Otot
¼ KPFK:
Denoting the total enzyme concentration Etot, so that Otot ¼ 12 ðEtot  TtotÞ,
we obtain
Otot
Ttot
¼ 1
16
1
Etot
2KPFK
 1=2
 1
4
: (A8)
When making the approximation O=T  Otot=Ttot, we obtain
S
PFK
0:5 ¼
1
4
1
2VPFK
kcatKPFK
 1=2
1
1
2
K
1
T 1K
1
O
1
4
1
2VPFK
kcatKPFK
 1=2
 1
2
 ! ; (A9)
where we have used the standard deﬁnition VPFK ¼ kcatEtot. Assuming that
F6P has greater afﬁnity to the tetramer than to the octamer, i.e. KT\KO, Eq.
A9 tells us how the value of the apparent substrate-enzyme dissociation
constant SPFK0:5 would increase when the PFK concentration is raised.
However, we stress that Eq. A9 is of an approximative nature and should
only be viewed as reﬂecting a qualitative relationship, not to be
quantitatively exact. Finally, from Eq. A8 it is apparent that whenOtot¼ Ttot,
Etot
KPFK
¼ VPFK
kcatKPFK
¼ 3: (A10)
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